BioNano Genomics, Inc. (BNGO) Reports Q1 EPS of $0.00
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Bionano Genomics Reports First Quarter 2021 Financial Results and Highlights Recent Business Progress
May 13, 2021 4:01 PM EDT179% year-over-year revenue increase driven by record sales of consumables and growth in the Saphyr installed baseAll 2021 milestones on trackStrong balance sheet with $362 million cash as of March 31, 2021Conference call today, Thursday, May 13, at 4:30 pm ET
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the first quarter ended March 31, 2021 and highlighted recent corporate updates.
2021 is off to a... More
